X
Translate:
Media Inquiries?
Please call

08/27/20

RUTGERS NEW JERSEY MEDICAL SCHOOL AND UNIVERSITY HOSPITAL BEGIN RECRUITING HEALTHY ADULTS FOR COVID-19 VACCINE CLINICAL TRIAL

Rutgers New Jersey Medical School (NJMS) and University Hospital (UH) announced today that they are recruiting healthy adults for a Phase 3 clinical research study to evaluate the safety and effectiveness of mRNA-1273, a vaccine candidate against COVID-19. Sponsored by Moderna, the COVE Study is recruiting healthy volunteers ages 18 or older in high-risk populations, including the elderly, racial and ethnic minorities at higher risk for COVID-19, and essential workers in close contact with potentially infected persons.

The Phase 3 study will evaluate if mRNA-1273 boosts the immune system to produce enough antibodies against SARS-CoV-2, the virus that causes COVID-19, so it does not cause illness in case of infection.

“We are excited and hopeful as we begin participating in the COVE Study, understanding this is one of the most important and impactful clinical research studies in our lifetime,” said Shobha Swaminathan, Principal Investigator, Rutgers NJMS and Medical Director, Infectious Diseases Practice, UH. “We encourage individuals across the state to consider participating in this trial, which could bring the world one step closer to ending this global health crisis.”

To be eligible for the study, healthy volunteers must be 18 years of age and older with no known history of SARS-CoV-2 infection or previous participation in an investigational coronavirus vaccine. Within this population, Rutgers NJMS and UH, Newark, NJ are prioritizing candidates whose locations or circumstances put them at higher risk of exposure to the virus, including:

  • Elderly, ages 65 and older
  • Essential workers in close contact with potentially infected persons, including, but not limited to, healthcare and hospital workers, first responders, transit employees, institutional residents or workers, factory employees, and teachers and students
  • Racial and ethnic minorities at high risk for COVID-19

If a person is eligible and decides to participate, the research staff at Rutgers NJMS will randomize patients to receive either the mRNA-1273 vaccine or a matching placebo. The total length of participation is 25 months and includes approximately six visits to the clinic and 25 phone calls.

Rutgers NJMS is one of 89 research sites across the country participating in the COVE Study. If someone is interested in participating in clinical research in their area, call 1 844-782-6765 or email thecovestudy@njms.rutgers.edu to learn more.

Other Recent News Stories
05/25/23

UNIVERSITY HOSPITAL TRAUMA RECOVERY PROGRAMS RECOGNIZED BY STATE OF NEW JERSEY; SIMILAR WORK, IN PARTNERSHIP WITH THE CITY OF NEWARK, HONORED BY OBAMA FOUNDATION

The Trauma Recovery Center (TRC) and Hospital-Based Violence Intervention Program (HVIP) at University Hospital (UH) recently received the Crime Victims’ Rights Award by the State of New Jersey. Additionally, the work of both programs, in partnership with the City of Newark, were honored as part of the City’s recognition as a My Brother’s Keeper (MBK) …

UNIVERSITY HOSPITAL TRAUMA RECOVERY PROGRAMS RECOGNIZED BY STATE OF NEW JERSEY; SIMILAR WORK, IN PARTNERSHIP WITH THE CITY OF NEWARK, HONORED BY OBAMA FOUNDATION Read More »

More
01/06/20

UNIVERSITY HOSPITAL ANNOUNCES 50% REDUCTION IN LENGTH OF STAY FOR NEONATAL ABSTINENCE SYNDROME BABIES AS A RESULT OF ITS HIGHLY SUCCESSFUL N.A.S.T.O.P. PROGRAM

University Hospital announced today that its Neonatal Abstinence Syndrome Treatment & Observation Protocols (N.A.S.T.O.P.) program has successfully reduced the average length of stay duration for babies suffering from neonatal abstinence syndrome by more than 50%, from more than 42 to days to fewer than 20 days. The program has also decreased the neonatal abstinence treatment …

UNIVERSITY HOSPITAL ANNOUNCES 50% REDUCTION IN LENGTH OF STAY FOR NEONATAL ABSTINENCE SYNDROME BABIES AS A RESULT OF ITS HIGHLY SUCCESSFUL N.A.S.T.O.P. PROGRAM Read More »

More
01/09/20

UNIVERSITY HOSPITAL AND FIRST LADY TAMMY MURPHY HOST SURGEON GENERAL FOR MATERNAL HEALTH LISTENING SESSION

On Thursday, January 9th , University Hospital and First Lady Tammy Murphy hosted Surgeon General, VADM Jerome M. Adams, M.D., M.P.H., for a Maternal Mortality & Morbidity Listening Session. Dr. Adams moderated a panel discussion with healthcare providers, State and local leaders, and other stakeholders on the efforts underway in New Jersey to address these …

UNIVERSITY HOSPITAL AND FIRST LADY TAMMY MURPHY HOST SURGEON GENERAL FOR MATERNAL HEALTH LISTENING SESSION Read More »

More
Scroll to Top